Ain Holdings Inc. · TSE:9627
Ain — Ain Pharmaciez — 2Q FY2010 Earnings Presentation
36 slides from Ain's earnings presentation, Dec 10, 2009
Slide 1: Ain Pharmaciez
Zz 41 AIN PHARMAGEZ taisat P71 Ip-VIA 2009 12 10
Slide 2: 1.
1.
Slide 3: 2Q consolidated results summary
2Q 105.1 09/42Q 10/42Q % % 56,859 59,740 2,881 98.8 105.1 7,157 8,075 918 104.5 112.8 % 12.6 13.5 4,985 5,229 244 97.2 104.9 % 8.8 8.8 2,172 2,846 674 121.1 131.0 % 3.8 4.8 2,070 2,762 692 124.4 133.4 % 3.6 4.6 830 1,349 519 153.3 162.5 1 68.59 101.01 32.42 147.3 147.3 2.
Slide 4: Segment results: dispensing
106.0 131.9 09/4 10/4 2Q 2Q % % 3,011 49,877 52,891 3,014 100.0 106.0 246 5,157 6,112 246 955 109.6 118.5 3 % 10.3 11.6 2,364 2,429 65 96.1 102.7 % 4.7 4.6 2,792 3,682 890 120.8 131.9 % 5.6 7.0 2,838 3,712 874 118.5 130.8 % 5.7 7.0 2Q 360 380 20 96.9 105.6 4,802 4,797 5 97.8 99.9 10,182 10,822 640 1
Slide 5: Segment results: drug and cosmetic
98.0 198 09/4 10/4 2Q 2Q % % 459 6,849 6,711 138 90.7 98.0 581 2,037 1,998 33 39 91.4 98.1 304 % 29.7 29.8 11 2,146 2,237 91 100.2 104.2 % 31.3 33.3 109 238 129 % % 73 198 125 2Q 45 46 1 95.8 102.2 2Q 18,367 18,349 18 99.9 1,979 2,028 49 102.5 3,460 3,303 157 95.5 4.
Slide 6: Balance sheet
B/S 09/4 10/4 2Q 2Q 25,410 31,853 31,277 34,153 4,775 7,319 12,198 6,889 35,300 13,937 34,065 11,551 1,940 12,604 2,766 9,834 14,920 17 19,655 60,710 60,710 65,360 65,360 19,923 16,724 3,199 13,208 1,759 09/4 2Q 10/4 2Q 1 5.
Slide 7: Balance sheet: assets detail
09/4 2Q 10/4 2Q 4,775 12,198 7,423 11,237 9,328 1,909 5,745 6,440 695 25,410 31,277 5,867 5,892 5,943 51 4,972 5,011 39 11,980 12,329 349 13,773 13,180 593 1,940 2,766 826 948 839 109 6,143 4,314 1,829 9,546 8,556 990 35,300 34,065 1,235 705473 6.
Slide 8: Balance sheet: liabilities and equity
4,735 09/4 2Q 10/4 2Q 18,212 19,692 1,480 1 7,319 6,889 430 31,853 34,153 2,300 12,604 9,834 2,770 13,937 11,551 2,386 45,790 45,705 85 5,047 6,308 1,261 4,237 5,498 1,261 5,830 8,092 2,262 15,111 19,894 4,783 14,920 19,655 4,735 60,710 65,360 4,650 7.
Slide 9: Cash flow and M&A
30.0 5.5% M&A 09/4 2Q 10/4 2Q 889 4,298 5,187 1,271 1,406 135 2,741 73 2,668 4,775 12,198 7,423 24.5 30.0 5.5 39.3 57.8 18.5 24.0 72.9 48.9 8.
Slide 10: Financial indicators
10/409/4 09/4 10/4 09/4 2Q 2Q 2Q 13.57 8.67 13.27 0.3 68.59 170.74 101.01 32.42 1.60 1.18 1.92 0.32 1,161.24 1,252.54 1,391.01 229.77 1.4 3.6 2.1 0.7 6.2 15.1 7.6 1.4 5,261 7,275 7,250 1,989 7.26 3.79 5.62 1.64 0.87 0.45 0.09 0.84 0.78 13,208 7,391 1,759 11,449 24,995 20,161 38,993 13,998 23,858 19,
Slide 11: Full-year forecast: consolidated
10/4 7.3 09/4 10/4 10/4 % % 101,876 113,129 113,242 100.1 111.2 11,332 12,386 12,946 104.5 114.2 % 11.1 11.0 11.4 4,573 4,991 5,012 100.4 109.6 % 4.5 4.4 4.4 6,761 7,395 7,933 107.3 117.3 % 6.6 6.5 7.0 6,835 7,577 8,140 107.4 119.1 % 6.7 6.7 7.2 10.
Slide 12: Full-year forecast: segment
10/4 09/4 10/4 10/4 % % 13,251 13,602 13,482 99.1 101.7 3,994 4,146 4,113 99.2 103.0 % 30.1 30.5 30.5 4,283 4,162 4,522 108.6 105.6 % 32.3 30.6 33.5 289 15 409 % 202 82 324 % 0.6 11.
Slide 13: Forecast: consolidated
10/4 6,000 2,900 09/4 10/4 10/4 % % 115,387 127,000 127,000 100.0 110.1 15,245 16,450 16,980 103.2 111.4 % 13.2 13.0 13.4 9,948 10,400 10,830 % 104.1 108.9 8.6 8.2 8.5 5,296 6,050 6,150 101.7 116.1 % 4.6 4.8 4.8 5,041 5,850 6,000 % 102.6 119.0 4.4 4.6 4.7 2,127 2,800 2,900 103.6 136.3 170.74 218.17
Slide 14: 13.
13.
Slide 15: Holdings: drug and cosmetic business
HLDGS. @OTWVRWAIZX A|NZ@TULPE DRUG AND COSMETIC e “ye axatt CIVEP-HHLDGS. 14,
Slide 16: Dispensing pharmacy business results
1Q 2Q 99.2 106.0% 09/4 2Q 10/4 2Q 10/4 10/4 1Q-2Q 380 1Q 2Q 49,106 52,181 106.3 26,197 25,984 99.2 4,724 5,442 115.2 2,719 2,723 100.1 2,001 1,964 98.2 1,031 933 90.5 2,722 3,478 127.8 1,688 1,790 106.0 4,802 4,797 99.9 2,429 2,368 97.5 10,182 10,822 106.3 10,742 10,901 101.5 M&A 15.
Slide 17: Monthly trends
10 01/4 02/4 03/4 04/4 05/4 06/4 07/4 08/4 09/4 10/4 1.3 0% 0.6 +0.17 6.3 4.2 6.7 5.2 M&A 01/4-03/4 04/406/4 M&A 08/4 16.
Slide 18: Schedule and events
2009.11.13 2009.12.3 GE 2009.11.25 GE 20,25%,30% 2009.11.27 2009.11.27 2009.11.27 2009.11.27 17.
Slide 19: Forecast and targets
10/4 6.2 7.0 8.0 111,000 105,500 104,800 103,900 7,870 7,280 7,200 7,100 7.1% 6.9% 6.9% 6.8% 8,660 110 0% 6.2 7.0 8.0 6,580 11,500 12,160 13,000 790 1,380 1,460 1,560 117,580 117,000 116,960 116,900 (5.9%) (5.4%) (5.4%) (5.3%) 7.4% 7.4% 7.4% 7.4% GE 18.
Slide 20: 2Q 10/4 10/4 10/4 5 1 8 1 0 4 3 2 2 4
2Q 6 11 12 6 10/4 10/4 10/4 2 2 64 8 2 21 21 0 0 4 5 1 1 4 5 5 1 8 1 0 4 3 2 2 4 4 0 0 3 1 62 0 0 2 6 17 6 50 45 191 63 10/4 2Q 19.
Slide 21: Generic drug use
5mg GE OD 2.5mg 2 1 GE GE 20,25%,30% GE 20 25%,30%,50% GE GE 20% 25 30 50 A 20,000 6,490 430 68 870 135 2,610 405 32.5% 33.5 34.6 39.6 GE 20.
Slide 22: l l PDA
l R A DE LE l PDA 21.
Slide 23: PDA
3 22 PTP PTP1 1 PTP 3 100 09/9/24 09/11/9 09/11/16 PDA 22.
Slide 24: A 450ml 30ml 200ml
A 1 9 450ml 30ml 200ml 32 216 23.
Slide 25: / 35,000 16.7 2.0 1.0 4.0 1.5 1.2 4.0 3.0 2.0 1.0 2.0 1.0
/ 35,000 16.7 200 2.0 1.0 4.0 1.5 1.2 4.0 3.0 2.0 1.0 2.0 1.0 1.0 4.0 3.0 400 175 70 100 10 24.
Slide 26: WSS)
WSS) 4 06/4 07/4 08/4 09/4 09/9 10/4 07 06 06 07 08 09 09 5 4 08 08 6 9 10 10 4 5 5 7 11 06 4 DgS 07/9 10/9 293 06 07 9 4 0.6 0.17 6.7 5.2 25.
Slide 27: WSS
WSS 2Q GE 8,000 7,280 7,000 6,000 5,200 5,000 4,600 4,000 3,079 3,000 2,483 881 218 2,000 1,498 1,000 408 889 2,198 2,265 153 255 609 0 07/3 08/3 09/3 10/3 11/3 12/3 2Q WSS 26.
Slide 28: GE GE GE
GE GE GE 2007 2008 2009 2010 2011 2012 65,290 64,396 67,580 68,929 69,987 71,386 GE 3,062 3,091 3,379 3,597 4,199 5,071 (08/12/16 No08096) ((07/12/16 No154) GE 2008 9,263 7,557 3,925 2,779 2,228 2,170 1,828 1,666 21 27.
Slide 29: WSS
09 WSS 20081,871 5.3% 2008 2010 2011 2012 2013 542 1,070 572 145 339 913 561 131 266 514 274 131 143 177 330 123 28.
Slide 30: Store openings and network
03/4 04/4 05/4 06/4 07/4 08/4 09/4 0/4 & CFS 7&i UP MD & 1.7 3.0% NEW Open 2 3 4 3 3 3 5 5 Close 5 7 4 3 4 1 79 95 125 148 142 139 132 134 2 0.5 0.1 2 1.6 3.8 2 3 167 378 638 1,039 1,291 1,525 1,730 2,000 05/4 29.
Slide 31: DM MD
9 2,171 90 27.9 / DM 6 1,779 17 MD 28.1 2 425 29 25.0 2Q 30.
Slide 32: New store formats
AL ee” NEW 1127 NEW AINZ@TULPE DRUG AND COSMETIC No1 SEWBU 31.
Slide 33: 2009 100,000 / 217.6 200912 40,000 / 155.7 2010 2 40,000 456 / 87.7
11 12 2 3 2009 11 27 100,000 460 / 217.6 200912 3 40,000 257 / 155.7 2010 2 40,000 456 / 87.7 2010 4 10,000 320 / 32.8 2010 4 30,000 180 / 168.5 32.
Slide 34: Partnerships and new store openings
22 5OPEN 225 OPEN 30 2 nanaco 4 420 10 & 425 OPEN 80 6 7 OPEN 826 OPEN & 1111 7 OPEN 1127 OPEN 7 OPEN & 33.
Slide 35: 20096 1111 2009 2010 34.
34 20096 1111 22 34 2009 11 2010 3 11 11 34.
Slide 36: New store list
096 1 1 11 2 7 7-6-1 2009 8 6 930 15,000 10 1-1-15 2009 1111 1,100 15,000 8 3-2-12 2009 1127 660 Photo 17,000 45 35.